ILCN Lung Cancer News

Timely and relevant thoracic oncology news brought to you by the only true global association dedicated to the multi-disciplinary study of lung cancer.

ILCN Lung Cancer News

Timely and relevant thoracic oncology news brought to you by the only true global association dedicated to the multi-disciplinary study of lung cancer.

Featured Topics

View News by Topic

Diagnostic Oncology

Risk Assessment and Reduction

Early Detection & Screening

Nursing & Allied Health

Evolving Standards of Care

Patient Advocacy

Supportive & Palliative Care

Global Initiatives

Radiation Oncology

Surgical Oncology

Tobacco & Smoking Cessation

Regulatory News

Antibody-Drug Conjugates

Behind the Scenes

Clinical Trial Design

Disease Staging

Health Services

Industry News & Regulatory Approvals

Locoregional/Oligo

Lung Cancer Risk Reduction & Prevention

Lung Cancer Screening

Member Stories from the COVID-19 Era

Palliative Care

Pathologic Assessment

Patient Advocacy & Survivorship

Popular Articles

Presidential Symposium

Pro/Con Perspective

Regulatory Agency Perspective

Systemic, Targeted, & Immune Therapies

Targeted Therapies

Recent Posts

Overall Survival Benefit Seen in Interim Analysis of ARTEMIS-008 Signals Rapidly Expanding Landscape of ADC-Based Therapies in Small Cell Lung Cancer

September 14, 2026
Adjuvant Osimertinib Demonstrates Sustained OS Benefit in Resected EGFR-Mutated NSCLC

September 14, 2026
Overall Survival Benefit Not Seen with Amivantamab-Chemotherapy in Phase III PAPILLION Trial

September 14, 2026
Four Multidisciplinary Teams to Face Off During the Closing Lunch and Game Show

September 14, 2026